ELICERA's CSO and Co-founder MAGNUS ESSAND

BioStock Studio: Elicera’s immuno-oncology platform iTANK reaches high-impact journal

Gothenburg-based gene therapy company Elicera Therapeutics recently announced the publication of a scientific article describing the mechanism-of-action of its universal CAR T-cell enhancement technology...
Jeppe Øvlesen

BioStock Studio: SynAct Pharma’s CEO on the rights issue and partnering...

Today, the subscription period begins in SynAct Pharma's rights issue, which will primarily finance further clinical phase II development with AP1189 in rheumatoid arthritis....
BioStock Studio: Alligator Bioscience's CEO on the latest data

BioStock Studio: Alligator Bioscience’s CEO on the latest data

Lund-based biotech company Alligator Bioscience recently announced safety data from the phase II trial with lead candidate mitazalimab in pancreatic cancer in combination with...
Cereno Scientific releases report and looks ahead

BioStock Studio: Cereno Scientific releases report and looks ahead

Spotlight-listed biotech company Cereno Scientific recently released its year-end report for 2021. CEO Sten R Sörensen visited BioStock's studio to talk about activities in...
Cyxone updates on study results

BioStock Studio: Cyxone comments on the Covid-19 study result

Biotech company Cyxone has announced results from their phase II trial with drug candidate Rabeximod in patients with moderate to severe Covid-19. The data...

BioStock Studio: SynAct Pharma comments on the promising study results in...

SynAct Pharma has announced top-line results from BEGIN, a phase IIa study of AP1189 in rheumatoid arthritis. The company’s CEO Jeppe Øvlesen and CMO...

BioStock Studio: CLS’ CEO about Q3 and the road ahead

At the end of last week, Lundbased medtech company Clinical Laserthermia Systems, CLS, published its report for the third quarter 2021. The company's CEO...

BioStock Studio: Cereno Scientific’s CEO comments on the third quarter

Spotlight-listed Cereno Scientific recently released its third quarter report. During the period, the company reached several milestones, the most significant being when FDA accepted...

BioStock studio: Saniona celebrates a decade of progress

Today marks Saniona’s 10th anniversary since its founding. BioStock was visited in the studio by the company's founder Jørgen Drejer, now Chief Scientific Officer, who...
BioStock Studio: Ultimovacs reaches key milestones with UV1

BioStock Studio: Ultimovacs reaches key milestones with UV1

Norwegian Ultimovacs has made some big announcements recently, including discussions for a fifth phase II clinical trial with universal cancer vaccine UV1, a private...